Search

Search Constraints

You searched for: Author/Creator Heyl, Volker

Search Results

1. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Issue 5 (May 2022)

2. Evaluation of the methodological quality of articles on autologous breast reconstruction. Issue 9 (September 2018)

3. Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study. (June 2017)